19-45365033-T-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000400.4(ERCC2):​c.477+9A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00737 in 1,612,340 control chromosomes in the GnomAD database, including 630 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 75 hom., cov: 33)
Exomes 𝑓: 0.0071 ( 555 hom. )

Consequence

ERCC2
NM_000400.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.636
Variant links:
Genes affected
ERCC2 (HGNC:3434): (ERCC excision repair 2, TFIIH core complex helicase subunit) The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-45365033-T-G is Benign according to our data. Variant chr19-45365033-T-G is described in ClinVar as [Benign]. Clinvar id is 256022.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-45365033-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC2NM_000400.4 linkc.477+9A>C intron_variant Intron 6 of 22 ENST00000391945.10 NP_000391.1 P18074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC2ENST00000391945.10 linkc.477+9A>C intron_variant Intron 6 of 22 1 NM_000400.4 ENSP00000375809.4 P18074-1

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1523
AN:
152182
Hom.:
76
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00181
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0397
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.141
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00103
Gnomad OTH
AF:
0.00671
GnomAD3 exomes
AF:
0.0253
AC:
6342
AN:
250228
Hom.:
439
AF XY:
0.0211
AC XY:
2860
AN XY:
135430
show subpopulations
Gnomad AFR exome
AF:
0.00161
Gnomad AMR exome
AF:
0.0937
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.157
Gnomad SAS exome
AF:
0.00183
Gnomad FIN exome
AF:
0.000187
Gnomad NFE exome
AF:
0.000884
Gnomad OTH exome
AF:
0.00867
GnomAD4 exome
AF:
0.00709
AC:
10355
AN:
1460040
Hom.:
555
Cov.:
32
AF XY:
0.00653
AC XY:
4741
AN XY:
726464
show subpopulations
Gnomad4 AFR exome
AF:
0.000748
Gnomad4 AMR exome
AF:
0.0856
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.125
Gnomad4 SAS exome
AF:
0.00214
Gnomad4 FIN exome
AF:
0.000337
Gnomad4 NFE exome
AF:
0.000794
Gnomad4 OTH exome
AF:
0.00786
GnomAD4 genome
AF:
0.0100
AC:
1525
AN:
152300
Hom.:
75
Cov.:
33
AF XY:
0.0114
AC XY:
852
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.00180
Gnomad4 AMR
AF:
0.0399
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.141
Gnomad4 SAS
AF:
0.00498
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00103
Gnomad4 OTH
AF:
0.00664
Alfa
AF:
0.00245
Hom.:
5
Bravo
AF:
0.0164
Asia WGS
AF:
0.0410
AC:
143
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000890

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 28, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 05, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Xeroderma pigmentosum, group D Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.57
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1799785; hg19: chr19-45868291; COSMIC: COSV55538879; COSMIC: COSV55538879; API